| Component I (California Poison Control System Data Surveillance) Component I of this study involves data collection on all patients exposed to GHB and GHB analog/precursor treated in a health care facility for whom the California Poison Control System (CPCS) is consulted. This study includes males and females, pregnant women, all ethnic/racial groups and all ages. This data collection will be performed in accordance with existing CPCS policies and protection of patient confidentiality. Once the patient is fully oriented and prior to hospital discharge, study information sheets (Forms C & D) will be given to the patient and permission to release his/her home contact information to study investigators will be requested. For minors, parent/guardian permission will be obtained in addition to the permission of the minor patient (Form C, minor). Within two weeks of the subject’s GHB incident, study investigators will contact subjects (who have agreed to release their home contact information) to request their consent to review their medical records, include their test results in our study and possibly participate in a telephone interview for research purposes. These consent forms may be downloaded from this website [Forms E and F (and Forms E and F, Minors)] or will be mailed to the subjects. The forms will need to be signed by the subject and returned to study investigators in order to participate. Patient confidentiality will be maintained to the highest extent possible. The study has been granted a Certificate of Confidentiality to further protect patient confidentiality (http://grants.nih.gov/grants/policy/coc/index.htm). If the subject (or in the case of a minor, the parent/guardian) does not wish to participate, no further contact will be made. INFORMATION SHEETS: FORMS TO DOWNLOAD: |
